Adamis Pharms Corp Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ADAMIS PHARMS CORP
ADAMIS PHARMS CORP has one approved drug.
There is one US patent protecting ADAMIS PHARMS CORP drugs.
There are thirty patent family members on ADAMIS PHARMS CORP drugs in seventeen countries and two supplementary protection certificates in two countries.
Summary for Adamis Pharms Corp
| International Patents: | 30 |
| US Patents: | 1 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Adamis Pharms Corp
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adamis Pharms Corp | SYMJEPI | epinephrine | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 207534-002 | Sep 27, 2018 | DISCN | Yes | No | 11,141,540 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Adamis Pharms Corp | SYMJEPI | epinephrine | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 207534-001 | Jun 15, 2017 | RX | Yes | Yes | 11,141,540 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Adamis Pharms Corp Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 3199034 | ⤷ Start Trial |
| Australia | 2020202668 | ⤷ Start Trial |
| Japan | 2018531643 | ⤷ Start Trial |
| Portugal | 3341056 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Adamis Pharms Corp Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 3678649 | LUC00378 | Luxembourg | ⤷ Start Trial | PRODUCT NAME: COMBINAISON D'EPINEPHRINE ET DE DODECYLMALTOSIDE, SOUS TOUTES SES FORMES PROTEGEES PAR LE BREVET DE BASE; AUTHORISATION NUMBER AND DATE: EU/1/24/1846 20250211 |
| 3678649 | 2025C/508 | Belgium | ⤷ Start Trial | PRODUCT NAME: COMBINATIE VAN EPINEPHRINE EN DODECYLMALTOSIDE, IN ALLE VORMEN BESCHERMD DOOR HET BASISOCTROOI; AUTHORISATION NUMBER AND DATE: EU/1/24/1846 20240823 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
